Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanezumab SC in Osteoarthritis of Hip or Knee
NCT02709486Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2016
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 15
01
Overview
A Phase 3 trial of tanezumab in osteoarthritis (OA), sponsored by Pfizer. Started Mar 2016; status: completed.
02
Drugs
tanezumab
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02709486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02709486.